Free Trial
OTCMKTS:RZLTD

Rezolute (RZLTD) Stock Price, News & Analysis

$4.42 +0.20 (+4.62%)
As of 06/3/2025

About Rezolute Stock (OTCMKTS:RZLTD)

Key Stats

Today's Range
$4.16
$4.54
50-Day Range
$2.47
$4.23
52-Week Range
$16.00
$24.05
Volume
860,077 shs
Average Volume
4,788 shs
Market Capitalization
$37.21 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Rezolute, Inc., a clinical stage biopharmaceutical company, develops therapies for rare and metabolic diseases in the United States. The company's lead product candidate is RZ358, a human monoclonal antibody that is in Phase 2b clinical trial for the treatment of congenital hyperinsulinism, an ultra-rare pediatric genetic disorder. It also develops RZ402, a small molecule plasma kallikrein inhibitor, which is in preclinical stage for the treatment of diabetic macular edema. The company was formerly known as AntriaBio, Inc. and changed its name to Rezolute, Inc. in December 2017. Rezolute, Inc. was founded in 2010 and is headquartered in Redwood City, California.

Receive RZLTD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Rezolute and its competitors with MarketBeat's FREE daily newsletter.

RZLTD Stock News Headlines

Rezolute (RZLT) Earnings Dates & Reports
Xilio Development Inc (XLO)
The Trump Dump is starting; Get out of stocks now?
The first 365 days of the Trump presidency… Will be the best time to get rich in American history.
Systems Ltd.
See More Headlines

RZLTD Stock Analysis - Frequently Asked Questions

Rezolute's stock was trading at $4.96 at the beginning of the year. Since then, RZLTD shares have decreased by 10.9% and is now trading at $4.42.
View the best growth stocks for 2025 here
.

Shares of RZLTD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
N/A
Current Symbol
OTCMKTS:RZLTD
CIK
N/A
Fax
N/A
Employees
23
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$20.33 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Book Value
$1.24 per share
Price / Book
3.56

Miscellaneous

Free Float
N/A
Market Cap
$37.21 million
Optionable
Not Optionable
Beta
4.63
12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.

Get This Free Report

This page (OTCMKTS:RZLTD) was last updated on 6/4/2025 by MarketBeat.com Staff
From Our Partners